Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Republic HealthcareHKSE:08357 30 Market Cap is HK$64.27 Mil as of Aug. 24, 2026. GuruFocus rates HKSE:08357 with a GF Score™ of 30/100 and a GF Value™ of HK$0.09 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 693 Healthcare Providers & Services companies, Republic Healthcare ranks worse than 85.43% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Republic Healthcare's share price for the quarter that ended in Jun. 2026 was HK$0.128. Republic Healthcare's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 624.00 Mil. Therefore, Republic Healthcare's market cap for the quarter that ended in Jun. 2026 was HK$79.87 Mil.
Republic Healthcare's quarterly market cap
declined
from Jun. 2025 (HK$104.83 Mil) to Dec. 2025 (HK$87.36 Mil) and
declined
from Dec. 2025 (HK$87.36 Mil) to Jun. 2026 (HK$79.87 Mil).
Republic Healthcare's annual market cap
declined
from Dec. 2023 (HK$57.41 Mil) to Dec. 2024 (HK$39.31 Mil) but then
increased
from Dec. 2024 (HK$39.31 Mil) to Dec. 2025 (HK$87.36 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Republic Healthcare's Enterprise Value for Today is HK$52.05 Mil.
Republic Healthcare (HKSE:08357) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Republic Healthcare Market Cap Related Terms
Republic Healthcare Market Cap Historical Data
* Premium members only.
The historical data trend for Republic Healthcare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08357 vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, Republic Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Republic Healthcare Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Republic Healthcare's Market Cap distribution charts can be found below:
* The bar in red indicates where Republic Healthcare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Republic Healthcare's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Republic Healthcare (HKSE:08357) has a Market Cap of HK$64.27 Mil as of Aug. 24, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Republic Healthcare and its competitors. According to the industry distribution chart, Republic Healthcare ranks #592 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 85.4%.
Is Republic Healthcare's Market Cap too high?
Republic Healthcare's current Market Cap is HK$64.27 Mil. Based on the distribution chart, Republic Healthcare ranks #592 out of 693 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Republic Healthcare has a GF Score™ of 30/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Republic Healthcare's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Republic Healthcare ranks #592 out of 693 companies for Market Cap. This places Republic Healthcare in the lower half of its industry. The industry median Market Cap is 106.66. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 106.66, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Republic Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 106.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Republic Healthcare's current Market Cap is HK$64.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Republic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Republic Healthcare (HKSE:08357) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.10 — trading 14.4% above its estimated fair value. The current Market Cap is HK$64.27 Mil. Republic Healthcare's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Republic Healthcare (HKSE:08357), the current Market Cap is HK$64.27 Mil as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Republic Healthcare (HKSE:08357) Overvalued in 2026?
Based on GuruFocus' analysis, Republic Healthcare stock appears to be overvalued.
The current stock price of HK$0.10 is trading 14.4% above its estimated GF Value™ of HK$0.09.
GuruFocus considers Republic Healthcare to be Modestly Overvalued.
Key valuation signals for HKSE:08357:
Market Cap: HK$64.27 Mil
GF Value™: HK$0.09 vs. price of HK$0.10 (14.4% above fair value)
No single metric tells the full story. See the HKSE:08357 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Republic Healthcare Ltd is principally engaged in the clinic business in Singapore and the provision of management advisory services. The company provides healthcare services operating a network of general practice clinics, treatment solutions for common medical conditions with a focus on sexual health and infectious diseases, and operation of a medical aesthetics clinic that focuses on providing treatment solutions for common skin conditions and basic medical aesthetics services. The company is segments are medical services and education services. The Group is engaged in the operation of medical clinics and the provision of management advisory services, pepper trading business, and healthcare-related education business. It generates maximum revenue from Singapore.
30GF Score
Get the complete analysis for HKSE:08357
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08357 has been successfully added to your 
